Glutamine synthetase expression rescues human dendritic cell survival in a glutamine-deprived environment.
Robert SchoeppeNathalie BablSonja-Maria DeckingGabriele SchönhammerAndreas SiegmundChristina BrussKatja DettmerPeter J OefnerLinus FrickAnna WeigertJonathan JantschWolfgang HerrMichael RehliKathrin RennerMarina KreutzPublished in: Frontiers in oncology (2023)
Our results show that GS supports myeloid cell survival in a glutamine poor environment. Notably, in addition to suppressing proliferation and survival of tumor cells, the blockade of GS also targets immune cells such as DCs and macrophages.